Tirofiban

This classification denotes an antiplatelet agent with the molecular formula C22H36N2O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GGX234SI5H, chemically known as l-tyrosine, n-(butylsulfonyl)-o-(4-(4-piperidinyl)butyl)- but generally known as tirofiban, which bears US NIH Compound Identifier 60947. European Medicines Agency schedules Tirofiban in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11118MIG. The term TIROFIBAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 10, No. 3, 1996, List 36). World Health Organization schedules tirofiban in its Anatomical Therapeutic Chemical (ATC) Classification. TIROFIBAN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tirofiban under HS 29350090 and SITC 51580. As of Q4 2014, TIROFIBAN remains the US FDA Preferred Term for this commodity. Tirofiban bears US NLM identifiers UMLS ID C0247025 and NCI Concept Code C76405. SMILES: S(=O)(=O)(NC(Cc1ccc(OCCCCC2CCNCC2)cc1)C(=O)O)CCCC.